{"schema_version":"secwatch.filing_event.v1","accession":"0000009326-26-000026","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2026-07-31T11:32:28+00:00","discovered_at":"2026-07-31T11:35:00.258312+00:00","generated_at":"2026-07-31T11:35:05.808369+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Balchem Q2 net sales $284M (+11.2% YoY); record quarterly earnings; credit facility expanded to $650M","bullets":["Net sales $284.0M (+11.2% YoY); GAAP EPS $1.39 vs $1.17; adjusted EPS $1.49 vs $1.27.","Record quarterly net earnings $44.6M (+16.6%) and adjusted EBITDA $77.9M (+12.6%).","Credit agreement amended: borrowing capacity increased to $650M, maturity extended to July 24, 2031.","Repurchased $29M of stock in Q2, $114M over trailing twelve months.","All three reporting segments delivered sales and earnings growth."],"urls":{"canonical":"https://secwatch.observer/filing/0000009326-26-000026","json":"https://secwatch.observer/filing/0000009326-26-000026.json","markdown":"https://secwatch.observer/filing/0000009326-26-000026.md","text":"https://secwatch.observer/filing/0000009326-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000000932626000026/0000009326-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000000932626000026/bcpc-20260731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-31T11:35:05.808369+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}